Literature DB >> 1587415

Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters.

K W Heaton1, L J O'Donnell, F E Braddon, R A Mountford, A O Hughes, P J Cripps.   

Abstract

Because the prevalence of the irritable bowel syndrome (IBS) in the general population is unknown, a questionnaire of intestinal symptoms was administered to a stratified random sample of 1058 women and 838 men. Subjects were asked if they had consulted a physician about such symptoms. One or more symptoms occurred frequently in 47% of women and 27% of men. Diagnosable IBS, defined as three or more symptoms, was present in 13% of women and 5% of men. Abdominal pain was the most common symptom, and recurrent intestinal pain was reported by 20% of women and 10% of men. All symptoms were more common in women except runny or watery stools. Most symptoms including pain were unrelated to age. Only half the people with diagnosable IBS had consulted a physician about it. The likelihood of consulting a physician was directly proportional to the number of symptoms and was similar in men and women after controlling for the number of symptoms. Of individual symptoms, the one most strongly associated with consulting was abdominal pain, especially in men. It is concluded that IBS is prevalent at all ages, especially in women, that it is nearly always painful, and that people with multiple symptoms are more likely to consult a physician.

Entities:  

Mesh:

Year:  1992        PMID: 1587415     DOI: 10.1016/0016-5085(92)90320-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  93 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 2.  The role of psychosocial factors in gastrointestinal disorders.

Authors:  I Wilhelmsen
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

3.  A SEARCH FOR UNHAPPY ABDOMEN: PREVALENCE OF IRRITABLE BOWEL SYNDROME IN GENERAL POPULATION.

Authors:  A C Anand; G S Saiprasad; Rajvir Bhalwar
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

6.  Influence of functional bowel disease on outcome of surgical antireflux procedures.

Authors:  David A Axelrod; Vasu Divi; Majet M Ajluni; Frederic E Eckhauser; Lisa M Colletti
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

7.  Comparison of bowel patterns in Hispanics and non-Hispanic whites.

Authors:  M J Zuckerman; L G Guerra; D A Drossman; J A Foland; G G Gregory
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction.

Authors:  Y W Chia; C J Fowler; M A Kamm; M M Henry; M C Lemieux; M Swash
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

9.  Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire.

Authors:  Rolf Leibbrand; Ulrich Cuntz; Wolfgang Hiller
Journal:  Int J Behav Med       Date:  2002

10.  Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome.

Authors:  Olafur S Palsson; Olivier Morteau; Eugene M Bozymski; John T Woosley; R Balfour Sartor; Michael J Davies; David A Johnson; Marsha J Turner; William E Whitehead
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.